General Information of the Compound
Compound ID |
CP0340803
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-adamantyl(piperazin-1-yl)methanone
Show/Hide
|
||||||||||||||||||
Synonyms |
1-(1-adamantanecarbonyl)piperazine
1-(1-adamantylcarbonyl)piperazine
29869-08-7
AB00983558-01
AC1Q5KAX
AKOS009097513
ALBB-024506
Adamantan-1-yl-piperazin-1-yl-methanone
BBL037233
BDBM50207783
CHEMBL391335
CTK4G3954
DTXSID70589438
EN300-25317
MCULE-3925280273
MolPort-006-345-515
SBB071957
SCHEMBL1150471
ST072044
STL412114
XAFSAELWLMDLKL-UHFFFAOYSA-N
ZINC12343593
adamantan-1-yl-piperazin-1-yl-methanone
adamantanyl piperazinyl ketone
piperazin-1-yl(tricyclo[3.3.1.1~3,7~]dec-1-yl)methanone
piperazine, 1-(tricyclo[3.3.1.1~3,7~]dec-1-ylcarbonyl)-
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C15H24N2O
|
||||||||||||||||||
Molecular Weight |
248.37
|
||||||||||||||||||
Canonical SMILES |
O=C(N1CCNCC1)C12CC3CC(CC(C3)C1)C2
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C15H24N2O/c18-14(17-3-1-16-2-4-17)15-8-11-5-12(9-15)7-13(6-11)10-15/h11-13,16H,1-10H2
Show/Hide
|
||||||||||||||||||
InChIKey |
XAFSAELWLMDLKL-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound